The government plans to strictly limit foreign investment in firms that make medical goods and drugs amid the COVID-19 pandemic, sources said Wednesday. The government fears...
Treating the new coronavirus with hydroxychloroquine is associated with an increase in overall mortality, according to new research involving U.S. veterans. The combination of hydroxychloroquine and...
The race to develop an effective vaccine against the novel coronavirus gathered pace this week, as clinical trials on humans were approved in Germany and launched in the...
All member nations of the World Health Organization (WHO) should support a proposed independent review into the coronavirus pandemic, Australia’s Prime Minister Scott Morrison said on...
Britain’s government plans to test a sample of 20,000 English households for COVID-19 in the coming weeks to try to establish how far the disease has...
Cytovance® Biologics, a USA-based contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (“Hepalink”) announced today that it has entered...
Reaction Biology Corp. (“RBC”), a US-based preclinical CRO with offices in Pennsylvania and Germany, and PharmaCore Labs (PCL) Co., Ltd, a Chinese firm with offices in Haimen, China, today announced a...
Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostic company, today announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity...
CNS PHARMACEUTICALS AG Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced it has filed...
On March 16, Moderna and the National Institute of Allergy & Infectious Diseases (NIAID) began dosing patients with mRNA-1273, its vaccine candidate against COVID-19. The second round of dosing in healthy Seattle volunteers...
Chest CT at a radiation dose under 1 mSv can accurately and rapidly assess COVID-19 infection in emergency room patients — particularly those who have had...
Vuzix® Corporation (NASDAQ: VUZI), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, together with Librestream Technologies Inc., a leading provider of augmented reality...
Medical technology company Itamar Medical has funded the clinical study designed to assess the potential impact of continuous positive airway pressure (CPAP) therapy in the patients...
US-based medical device company Cerus Endovascular has secured CE Mark approval for its Neqstent Coil Assisted Flow Diverter device. The flow diverter is intended to treat intracranial...
IntraOp Medical, a provider of portable electron-beam therapy, has enrolled first patient in to the Cosmopolitan Trial, a randomised study of radiation therapy for breast cancer....
Copyright © 2024 Medical Buyer